BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 28243945)

  • 1. Tissue thioredoxin-interacting protein expression predicted recurrence in patients with meningiomas.
    Cai Z; Zhang C; Zou Y; Lu C; Hu H; Qian J; Jiang L; Hu G
    Int J Clin Oncol; 2017 Aug; 22(4):660-666. PubMed ID: 28243945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A study of UbcH10 expression and its association with recurrence of meningiomas.
    Jiang L; Wang T; Bao Y; Qian J; Wu XJ; Hu GH; Lu YC
    J Surg Oncol; 2012 Sep; 106(3):327-31. PubMed ID: 22095464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AKT2 expression in histopathologic grading and recurrence of meningiomas.
    Wang Q; Fan SY; Qian J; Wang JY; Lu YC; Hu GH; Luo C
    Eur J Surg Oncol; 2014 Sep; 40(9):1056-61. PubMed ID: 24656454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of EGFR expression in de novo and progressed atypical and anaplastic meningiomas: an immunohistochemical and fluorescence in situ hybridization pilot study.
    Caltabiano R; Barbagallo GM; Castaing M; Cassenti A; Senetta R; Cassoni P; Albanese V; Lanzafame S
    J Neurosurg Sci; 2013 Jun; 57(2):139-51. PubMed ID: 23486338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical expression of SPARC is correlated with recurrence, survival and malignant potential in meningiomas.
    Bozkurt SU; Ayan E; Bolukbasi F; Elmaci I; Pamir N; Sav A
    APMIS; 2009 Sep; 117(9):651-9. PubMed ID: 19703125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between laminin γ1 expression and meningioma grade, recurrence, and progression-free survival.
    Ke HL; Ke RH; Li B; Wang XH; Wang YN; Wang XQ
    Acta Neurochir (Wien); 2013 Jan; 155(1):165-71. PubMed ID: 23053286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ki-67 index as a predictive marker of meningioma recurrence following surgical resection.
    Mizrachi M; Hartley B; Saleem S; Hintz E; Ziemba Y; Li J; Goenka A; Schulder M
    J Clin Neurosci; 2024 Jun; 124():15-19. PubMed ID: 38631196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thioredoxin-Interact ing-Pro t e in [TXNIP] and Transglutaminase 2 [TGM2] Expression in Meningiomas of Different Grades and the Role of Their Expression in Meningioma Recurrence and Prognosis.
    Harb OA; Elsayed WS; Ismail EI; Toam MM; Ammar MG
    Asian Pac J Cancer Prev; 2017 Aug; 18(8):2299-2308. PubMed ID: 28843270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ki-67 proliferative index predicts clinical outcome in patients with atypical or anaplastic meningioma.
    Bruna J; Brell M; Ferrer I; Gimenez-Bonafe P; Tortosa A
    Neuropathology; 2007 Apr; 27(2):114-20. PubMed ID: 17494511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does protein expression predict recurrence of benign World Health Organization grade I meningioma?
    Kärjä V; Sandell PJ; Kauppinen T; Alafuzoff I
    Hum Pathol; 2010 Feb; 41(2):199-207. PubMed ID: 19801161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteopontin expression is a valuable marker for prediction of short-term recurrence in WHO grade I benign meningiomas.
    Tseng KY; Chung MH; Sytwu HK; Lee HM; Chen KY; Chang C; Lin CK; Yen CH; Chen JH; Lin GJ; Ma HI; Yeh YS; Ju DT; Liu MY; Hueng DY
    J Neurooncol; 2010 Nov; 100(2):217-23. PubMed ID: 20428925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decrease in serine protease HtrA1 expression correlates with grade and recurrence in meningiomas.
    Önder E; Arıkök AT; Seçkin H; Alper M
    Adv Med Sci; 2015 Mar; 60(1):139-43. PubMed ID: 25687108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of p40 (∆Np63) protein in meningiomas, an unexpected finding: immunohistochemical study and evaluation of its possible prognostic role.
    Guadagno E; Del Basso De Caro M; Pignatiello S; Sciammarella C; Solari D; Cappabianca P; Maiuri F; Dones F
    J Neurooncol; 2016 Sep; 129(3):405-413. PubMed ID: 27394131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expression of HER2/neu in meningiomas: an immunohistochemistry and fluorescence in situ hybridization study].
    Wang CL; Mei JH; Wang SS; Xu S; Xu LL; Xiong YF
    Zhonghua Bing Li Xue Za Zhi; 2010 Mar; 39(3):156-60. PubMed ID: 20450760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of somatostatin receptors (SSTR1-SSTR5) in meningiomas and its clinicopathological significance.
    Silva CB; Ongaratti BR; Trott G; Haag T; Ferreira NP; Leães CG; Pereira-Lima JF; Oliveira Mda C
    Int J Clin Exp Pathol; 2015; 8(10):13185-92. PubMed ID: 26722517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathological variables, immunophenotype, chromosome 1p36 loss and tumour recurrence of 247 meningiomas grade I and II.
    Ruiz J; Martínez A; Hernández S; Zimman H; Ferrer M; Fernández C; Sáez M; López-Asenjo JA; Sanz-Ortega J
    Histol Histopathol; 2010 Mar; 25(3):341-9. PubMed ID: 20054806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p-CREB expression in human meningiomas: correlation with angiogenesis and recurrence risk.
    Barresi V; Branca G; Caffo M; Tuccari G
    J Neurooncol; 2015 Mar; 122(1):87-95. PubMed ID: 25563814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Periostin: a novel prognostic predictor for meningiomas.
    Liu Y; Shi J; Chen M; Cao YF; Liu YW; Pan J; Qi ST
    J Neurooncol; 2015 Feb; 121(3):505-12. PubMed ID: 25519301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of COX-2 and VEGF expression in histopathologic grading and invasiveness of meningiomas.
    Lee SH; Lee YS; Hong YG; Kang CS
    APMIS; 2014 Jan; 122(1):16-24. PubMed ID: 23756256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of STMN1 is associated with the prognosis of meningioma patients.
    Wang H; Li W; Wang G; Zhang S; Bie L
    Neurosci Lett; 2017 Jul; 654():1-5. PubMed ID: 28625575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.